Alan Landay to AIDS Vaccines
This is a "connection" page, showing publications Alan Landay has written about AIDS Vaccines.
Connection Strength
1.179
-
Editorial: Advances in T Cell Therapeutic Vaccines for HIV. Front Immunol. 2022; 13:905836.
Score: 0.217
-
HIV immunology better understood and vaccination attempts started. AIDS. 2002; 16 Suppl 4:S85-8.
Score: 0.212
-
Vaccines and immunology. Recent advances in HIV/AIDS vaccine development. AIDS. 2001; 15 Suppl 5:S101-3.
Score: 0.198
-
A Summary of the Third Annual HIV Microbiome Workshop. AIDS Res Hum Retroviruses. 2018 10; 34(10):828-834.
Score: 0.169
-
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):163-71.
Score: 0.141
-
Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary. AIDS Res Hum Retroviruses. 2012 Nov; 28(11):1389-96.
Score: 0.112
-
Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science. 2004 Jan 16; 303(5656):316.
Score: 0.061
-
A look at HIV immune research. Interview by Alan Huff. Res Initiat Treat Action. 2000 Sep; 6(3):30-3.
Score: 0.048
-
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003 Jan 15; 187(2):320-5.
Score: 0.014
-
Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology. 1993 Aug; 195(2):475-80.
Score: 0.007